Role of guanylate cyclase modulators in decompensated heart failure. - Wikidata - wikimedia - TriplyDB

Role of guanylate cyclase modulators in decompensated heart failure.

Role of guanylate cyclase modulators in decompensated heart failure.

http://www.wikidata.org/entity/Q37537154

about

Insights into Soluble Guanylyl Cyclase Activation Derived from Improved Heme-Mimetics Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case Potential new drug treatments for congestive heart failure.Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.cGMP Signaling, Phosphodiesterases and Major Depressive Disorder.The current and future management of acute heart failure syndromes.Can we prevent or treat renal dysfunction in acute heart failure?Novel therapeutic targets for the treatment of heart failure.Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.Natriuretic peptides in therapy for decompensated heart failure.Novel vasodilators in heart failure.Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?Agents with vasodilator properties in acute heart failure.Update on the Management of Acute Decompensated Heart Failure.Influence of cinaciguat on gastrointestinal motility in apo-sGC mice.

P2860

Q27680135-9D35517F-0C59-444F-81CE-B40AE271F561 Q28550867-141EBD9C-9686-42EC-93A5-CCD354F8E675 Q30251531-FA9C7EB9-E616-45F3-9671-AECAF5557310 Q35010064-882AA271-F810-4D4E-94C0-73D5743E160D Q35203569-4F96C2BD-AE5F-4F1E-BF7D-C674C08F75FF Q35687052-A139E3A3-5FD6-4766-8663-BE3AD975A643 Q37703984-66365582-244E-4300-ADF9-AEC3022DE82D Q37873812-88177C19-E609-4945-A6D4-DCE7BDE45D8B Q37893956-DD4DC834-356D-40D0-8ADD-E2486E9311F3 Q37900203-E980A471-ECAD-4057-9114-3EC972C86CBF Q37928970-0DD0DB8E-0320-41FA-973F-2D424F925401 Q38072635-ED11C71E-3572-4F08-808D-899E9068C981 Q38509576-51DE2765-6195-426F-BC1F-C2E950D46E79 Q38818645-138061AF-94AC-4E33-9552-879C863C34D2 Q38959942-74CE7185-3835-4C58-A7B0-83D736EC817C Q39258163-548BEAC1-382E-4B7E-A6D6-09405C5DB8D4 Q49047822-BAAE28C8-D1B4-4818-A77D-2071458675D5

P2860

Role of guanylate cyclase modulators in decompensated heart failure.

http://www.wikidata.org/entity/Q37537154

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of guanylate cyclase modulators in decompensated heart failure.

@en

Role of guanylate cyclase modulators in decompensated heart failure.

@nl

type

label

Role of guanylate cyclase modulators in decompensated heart failure.

@en

Role of guanylate cyclase modulators in decompensated heart failure.

@nl

prefLabel

Role of guanylate cyclase modulators in decompensated heart failure.

@en

Role of guanylate cyclase modulators in decompensated heart failure.

@nl

P1433

Q37537154-97EF3E21-E2A6-44E2-AF91-DACCB994C1C4

P1476

Q37537154-9EC99A1F-626F-46F4-89F7-612D12195065

P2093

Q37537154-7CFF21DC-0F7D-4B25-9B0D-673D2AC2F556

Q37537154-B0C1D1BD-D4DB-4F7E-B549-EBB95B6C6B58

Q37537154-CC121EA4-3161-478C-9663-3C5964134CDD

P2860

Q37537154-94D963E6-1BA2-4374-B50A-4A19229E6004

Q37537154-CF4E9A73-4B4A-4662-B78E-C90D2E483B3B

Q37537154-CF83641A-7F1E-442B-8BA8-CEA0BD880070

Q37537154-DDB1B3FD-DEF9-4FBF-AFC5-8CD492547572

P2888

Q37537154-3CF23EAE-3210-4A6A-A5D4-3B02D67245D2

P304

Q37537154-3698D72B-75FE-4221-A423-15F01ACBDF66

P31

Q37537154-3CF33BE0-C1BF-475F-A27E-AB22CB667524

P356

Q37537154-49DC8654-16B4-4BFF-AB80-33673DF8300B

P433

Q37537154-2C4CF1FC-52CB-48F4-BEFF-36697630BFB6

P478

Q37537154-5E707D96-93D4-4D60-9178-C67A8A9343E1

P50

Q37537154-B2466302-3312-4059-965D-54948875D738

P577

Q37537154-2C82F367-B683-4121-85D3-A17D9B48EC02

P698

Q37537154-23D05759-4F1B-4D48-9EB0-38F316F4F9DE

P921

Q37537154-B5458B1B-9CDE-4A97-84AC-FDF04659ACFB

P356

S10741-009-9149-7

P1433

Heart Failure Reviews

P1476

Role of guanylate cyclase modulators in decompensated heart failure.

@en

P2093

Adrian F Hernandez

http://www.w3.org/2001/XMLSchema#string

Markus Meyer

http://www.w3.org/2001/XMLSchema#string

Veselin Mitrovic

http://www.w3.org/2001/XMLSchema#string

P2860

Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study.

Management of acute decompensated heart failure.

Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

P2888

s10741-009-9149-7

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-009-9149-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Mihai Gheorghiade

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19568931

http://www.w3.org/2001/XMLSchema#string

P921